U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 14:09:03 GMT 2023
Edited
by admin
on Sat Dec 16 14:09:03 GMT 2023
Protein Sub Type IGE
Sequence Origin HUMAN
Sequence Type INCOMPLETE
Record UNII
AF59OKU9U8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IMMUNOGLOBULIN E HEAVY CHAIN CONSTANT REGION
Common Name English
HUMAN IMMUNOGLOBULIN E CONSTANT REGION
Common Name English
Code System Code Type Description
FDA UNII
AF59OKU9U8
Created by admin on Sat Dec 16 14:09:04 GMT 2023 , Edited by admin on Sat Dec 16 14:09:04 GMT 2023
PRIMARY
UNIPROT
P01854
Created by admin on Sat Dec 16 14:09:04 GMT 2023 , Edited by admin on Sat Dec 16 14:09:04 GMT 2023
PRIMARY
From To
1_14 2_14
1_15 1_101
1_29 1_83
1_117 2_117
1_130 1_188
1_204 2_204
1_234 1_294
1_340 1_400
2_15 2_101
2_29 2_83
2_130 2_188
2_234 2_294
2_340 2_400
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_21
N 1_49
N 1_95
N 1_141
N 1_247
N 1_259
N 1_270
N 2_21
N 2_49
N 2_95
N 2_141
N 2_247
N 2_259
N 2_270
Related Record Type Details
INHIBITOR -> TARGET
Omalizumab inhibits the binding of IgE to FcεRI on mast cells and basophils by binding to an antigenic epitope on IgE that overlaps with the site to which FcεRI binds.
BINDING
INHIBITOR -> TARGET
INHIBITOR -> TARGET
BINDER->LIGAND
LIGAND->TARGET
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL